Prenatal Genetic Diagnostic Tests
Frequently Asked Questions Expand All
Genetic disorders are caused by changes in a person’s genes or chromosomes. Aneuploidy is a condition in which there are missing or extra chromosomes. In a trisomy, there is an extra chromosome. In a monosomy, a chromosome is missing. Inherited disorders are caused by changes in genes called mutations. Inherited disorders include sickle cell disease, cystic fibrosis, Tay-Sachs disease, and many others. In most cases, both parents must carry the same gene to have an affected child.
There are two general types of prenatal tests for genetic disorders:
Prenatal diagnostic tests: These tests can tell you, with as much certainty as possible, whether your fetus actually has an aneuploidy or specific inherited disorders for which you request testing. These tests are done on cells from the fetus or placenta obtained through amniocentesis or chorionic villus sampling (CVS). This FAQ focuses on these tests.
Both screening and diagnostic testing are offered to all pregnant women.
Amniocentesis is a diagnostic test. It usually is done between 15 weeks and 20 weeks of pregnancy, but it also can be done up until you give birth. To perform the test, a very thin needle is used to withdraw a small amount of amniotic fluid. Ultrasound is used to guide the procedure. Depending on the way the cells are analyzed and the information that you want, results can take from 1 day to several weeks. There is a very small chance of pregnancy loss with amniocentesis. Leakage of amniotic fluid and slight bleeding can occur after amniocentesis. In most cases, both stop on their own.
In CVS, a sample of tissue is taken from the placenta. The main advantage of having CVS over amniocentesis is that CVS is performed earlier than amniocentesis, between 10 weeks and 13 weeks of pregnancy. The chance of miscarriage with CVS is slightly higher than the chance of miscarriage with amniocentesis.
Preimplantation genetic diagnosis may be offered to couples who are using in vitro fertilization (IVF) to become pregnant and who are at increased risk of having a baby with a genetic or chromosomal disorder. Before an embryo is transferred to a woman’s uterus, it is tested for certain genetic disorders and mutations. Only embryos that do not test positive for the disorders are transferred.
A number of technologies are used in prenatal diagnostic testing. Your obstetrician or genetic counselor can assess what information is being sought and help select the tests that are best for your situation:
Karyotype—Missing, extra, or damaged chromosomes can be detected by taking a picture of the chromosomes and arranging them in order from largest to smallest. Karyotyping results are ready in 1–2 weeks after the cells are sampled.
Fluorescence in situ hybridization (FISH)—This technique can be used to detect common aneuploidies involving chromosomes 13, 18, and 21 and the X and Y chromosomes. Results are ready more quickly (usually within 1–2 days) than with traditional karyotyping. Positive test results are confirmed with a karyotype.
Chromosome microarray analysis—This test can look for different kinds of chromosome problems, including aneuploidy, throughout the entire set of chromosomes. It can find some chromosome problems that karyotyping can miss. Results can be ready in about 7 days.
DNA testing—Tests for specific gene mutations can be done by request. For example, if you and your partner are carriers of the cystic fibrosis gene, you may want to request prenatal diagnostic testing for this specific mutation.
Most of the time, the results of a diagnostic test are negative (normal). A negative result does not rule out the possibility that the fetus has a genetic disorder. It only tells you that the fetus does not have the particular disorder that was tested for.
If a diagnostic test result is positive (it shows that the fetus has the disorder tested for), your obstetrician or genetic counselor can explain the results and provide guidance about your choices and options. A specialist in the disorder can help you understand the life expectancy of the disorder, whether treatment is available, and the care that your child will need. Support groups, counselors, and social workers also can listen to your concerns and answer questions. It may be possible to have additional testing, such as a specialized ultrasound exam, to find out more detail about the defect.
It is your choice whether to have prenatal testing. Your personal beliefs and values are important factors in the decision about prenatal testing.
It can be helpful to think about what you would do if a diagnostic test result comes back positive. Some parents want to know beforehand if their child will be born with a genetic disorder. This gives parents time to learn about the disorder and plan for medical care that the child may need. If the disorder is very serious and the life expectancy is short, hospice care for the baby can be planned. Some parents may decide to end the pregnancy in certain situations. Other parents do not want to know this information before the child is born. They may decide not to have any testing at all. There is no right or wrong answer.
Keep in mind that certain tests can be done only at certain times during pregnancy. Tests that are done earlier allow parents more time to make decisions if a test result is positive. If ending the pregnancy is being considered, it is safer to do so within the first 13 weeks of pregnancy.
Any woman can choose to have diagnostic testing instead of or in addition to screening. The main benefit of having diagnostic testing instead of screening is that it can detect all conditions caused by an extra chromosome and many other disorders in which chromosomes are missing or damaged. Diagnostic tests also are available for many inherited disorders. The main disadvantage is that diagnostic testing carries a very small risk of losing the pregnancy. A genetic counselor or other health care professional with expertise in genetics can study your family health history, recommend specific tests, and interpret test results.
Amniocentesis: A procedure in which amniotic fluid and cells are taken from the uterus for testing. The procedure uses a needle to withdraw fluid and cells from the sac that holds the fetus.
Amniotic Fluid: Fluid in the sac that holds the fetus.
Aneuploidy: Having an abnormal number of chromosomes.
Cells: The smallest units of a structure in the body. Cells are the building blocks for all parts of the body.
Chorionic Villus Sampling (CVS): A procedure in which a small sample of cells is taken from the placenta and tested.
Chromosomes: Structures that are located inside each cell in the body. They contain the genes that determine a person’s physical makeup.
Cystic Fibrosis: An inherited disorder that causes problems with breathing and digestion.
Diagnostic Tests: Tests that look for a disease or cause of a disease.
DNA: The genetic material that is passed down from parent to child. DNA is packaged in structures called chromosomes.
Embryo: The stage of development that starts at fertilization (joining of an egg and sperm) and lasts up to 8 weeks.
Fetus: The stage of human development beyond 8 completed weeks after fertilization.
Fluorescence In Situ Hybridization (FISH): A screening test for common chromosome problems. The test is done using a tissue sample from an amniocentesis or chorionic villus test.
Genes: Segments of DNA that contain instructions for the development of a person’s physical traits and control of the processes in the body. The gene is the basic unit of heredity and can be passed from parent to child.
Genetic Counselor: A health care professional with special training in genetics who can provide expert advice about genetic disorders and prenatal testing.
Genetic Disorders: Disorders caused by a change in genes or chromosomes.
Hospice Care: Care that focuses on comfort for people who have an illness that will lead to death.
In Vitro Fertilization (IVF): A procedure in which an egg is removed from a woman’s ovary, fertilized in a laboratory with the man’s sperm, and then transferred to the woman’s uterus to achieve a pregnancy.
Karyotype: An image of a person’s chromosomes, arranged in order of size.
Microarray: A technology that examines all of a person’s genes to look for certain genetic disorders or abnormalities. Microarray technology can find very small genetic changes that can be missed by the routine genetic tests.
Monosomy: A condition in which there is a missing chromosome.
Mutations: Changes in a gene that can be passed on from parent to child.
Obstetrician: A doctor who cares for women during pregnancy and their labor.
Placenta: An organ that provides nutrients to and takes waste away from the fetus.
Preimplantation Genetic Diagnosis: A type of genetic testing that can be done during in vitro fertilization. Tests are done on the fertilized egg before it is transferred to the uterus.
Screening Tests: Tests that look for possible signs of disease in people who do not have signs or symptoms.
Sickle Cell Disease: An inherited disorder in which red blood cells have a crescent shape, which causes chronic anemia and episodes of pain.
Tay–Sachs Disease: An inherited disorder that causes intellectual disability, blindness, seizures, and death, usually by age 5.
Trisomy: A condition in which there is an extra chromosome.
Ultrasound Exam: A test in which sound waves are used to examine inner parts of the body. During pregnancy, ultrasound can be used to check the fetus.
Uterus: A muscular organ in the female pelvis. During pregnancy, this organ holds and nourishes the fetus.
Article continues below
ACOG does not endorse companies or products.
If you have further questions, contact your ob-gyn.
Last updated: October 2020
Last reviewed: January 2019
Copyright 2020 by the American College of Obstetricians and Gynecologists. Read copyright and permissions information.
This information is designed as an educational aid to patients and sets forth current information and opinions related to women’s health. It is not intended as a statement of the standard of care, nor does it comprise all proper treatments or methods of care. It is not a substitute for a treating clinician’s independent professional judgment. Read ACOG’s complete disclaimer.
Clinicians: Subscribe to Digital Pamphlets
Explore ACOG's library of patient education pamphlets.Pamphlets
ACOG does not endorse companies or products.